Publication | Open Access

Liraglutide reverses pronounced insulin-associated weight gain, improves glycaemic control and decreases insulin dose in patients with type 2 diabetes: a 26 week, randomised clinical trial (ELEGANT)

Metabolic SyndromeDiabetes ManagementInsulin DoseInsulin ManagementDiabetesPharmacologyType 2Insulin-associated Weight GainDiabetes MellitusMedicineInsulin Signaling